TIAA CREF Investment Management’s Abiomed Inc ABMD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $33.1M | Sell |
115,933
-52,536
| -31% | -$15M | 0.02% | 514 |
|
2018
Q4 | $54.8M | Sell |
168,469
-64,289
| -28% | -$20.9M | 0.04% | 370 |
|
2018
Q3 | $105M | Buy |
232,758
+53,671
| +30% | +$24.1M | 0.07% | 272 |
|
2018
Q2 | $73.3M | Buy |
179,087
+53,722
| +43% | +$22M | 0.05% | 344 |
|
2018
Q1 | $36.5M | Sell |
125,365
-40,323
| -24% | -$11.7M | 0.02% | 534 |
|
2017
Q4 | $31.1M | Sell |
165,688
-24,951
| -13% | -$4.68M | 0.02% | 589 |
|
2017
Q3 | $32.1M | Sell |
190,639
-1,920
| -1% | -$324K | 0.02% | 582 |
|
2017
Q2 | $27.6M | Sell |
192,559
-16,324
| -8% | -$2.34M | 0.02% | 624 |
|
2017
Q1 | $26.2M | Buy |
208,883
+75,292
| +56% | +$9.43M | 0.02% | 650 |
|
2016
Q4 | $15.1M | Sell |
133,591
-7,773
| -5% | -$876K | 0.01% | 883 |
|
2016
Q3 | $18.2K | Buy |
141,364
+5,549
| +4% | +$714 | 0.01% | 815 |
|
2016
Q2 | $14.8M | Sell |
135,815
-43,932
| -24% | -$4.8M | 0.01% | 855 |
|
2016
Q1 | $17M | Buy |
179,747
+7,886
| +5% | +$748K | 0.01% | 803 |
|
2015
Q4 | $15.5M | Sell |
171,861
-3,157
| -2% | -$285K | 0.01% | 853 |
|
2015
Q3 | $16.2M | Buy |
175,018
+24,938
| +17% | +$2.31M | 0.01% | 817 |
|
2015
Q2 | $9.87M | Buy |
150,080
+2,770
| +2% | +$182K | 0.01% | 1153 |
|
2015
Q1 | $10.5M | Sell |
147,310
-3,000
| -2% | -$215K | 0.01% | 1100 |
|
2014
Q4 | $5.72M | Sell |
150,310
-8,863
| -6% | -$337K | ﹤0.01% | 1537 |
|
2014
Q3 | $3.95M | Sell |
159,173
-4,392
| -3% | -$109K | ﹤0.01% | 1783 |
|
2014
Q2 | $4.11M | Sell |
163,565
-34,805
| -18% | -$875K | ﹤0.01% | 1828 |
|
2014
Q1 | $5.17M | Sell |
198,370
-2,720
| -1% | -$70.8K | ﹤0.01% | 1582 |
|
2013
Q4 | $5.38M | Sell |
201,090
-1,480
| -0.7% | -$39.6K | ﹤0.01% | 1587 |
|
2013
Q3 | $3.86M | Sell |
202,570
-2,844
| -1% | -$54.2K | ﹤0.01% | 1773 |
|
2013
Q2 | $4.43M | Buy |
+205,414
| New | +$4.43M | ﹤0.01% | 1615 |
|